Nalaganje...
Personalized treatment strategies for non-small-cell lung cancer in Chinese patients: the role of crizotinib
Anaplastic lymphoma kinase (ALK) rearrangement is an oncogene targeted with approved drugs second to epidermal growth factor receptor (EGFR) in lung cancer. Crizotinib was developed and introduced into clinical practice rapidly and successfully after the discovery of ALK rearrangement in non-small-c...
Shranjeno v:
| izdano v: | Onco Targets Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4427450/ https://ncbi.nlm.nih.gov/pubmed/25999733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S64664 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|